The Telegraph mentioned that GlaxoSmithKline GSK might be interested in buying Human Genome Sciences HGSI. The story mentioned Glaxo's synergistic interest in Benlysta. The report, published late last night, can be found here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
